Expansion of guidance for the day 8 initiation dose of paliperidone palmitate to avoid a missed dose

BACKGROUND: Paliperidone palmitate (PP) is a long-acting injectable formulation of an atypical antipsychotic, paliperidone. Its dose can be expressed in milligram or milligram equivalents (mg eq) of active paliperidone (39, 78, 117, 156, and 234 mg of PP correspond to 25, 50, 75, 100, and 150 mg eq...

Descripción completa

Detalles Bibliográficos
Autores principales: Samtani, Mahesh N, Nuamah, Isaac, Gopal, Srihari, Remmerie, Bart, Kern Sliwa, Jennifer, Alphs, Larry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665573/
https://www.ncbi.nlm.nih.gov/pubmed/23723704
http://dx.doi.org/10.2147/NDT.S40836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665573/
https://www.ncbi.nlm.nih.gov/pubmed/23723704
http://dx.doi.org/10.2147/NDT.S40836

Ejemplares similares